Surgalign Spine Technologies, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$5.3Mgeneral payments (2019-2025)
$172Kresearch payments (2019-2025)
1,320clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $2.2M
2020 $1.5M
2021 $874K
2022 $743K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Specialties it works with most

Orthopaedic Surgery of The Spine $1.9M
Neurological Surgery $1.3M
Orthopaedic Surgery $455K
Infectious Disease $436K
Blood Banking & Transfusion Medicine $221K
Plastic and Reconstructive Surgery $185K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Lennox Archibald Gainesville, FL Infectious Disease $435,959.77
Franco Vigna Niagara Falls, NY Orthopaedic Surgery of The Spine $221,393.74
Marek Fried Gainesville, FL Blood Banking & Transfusion Medicine $220,842.38
Richard Nussbaum Sherman Oaks, CA $212,994.28
Vittorio Morreale Shelby Twp, MI Neurological Surgery $175,983.16
Nicholas Mataragas Deerfield Beach, FL Orthopaedic Surgery of The Spine $173,586.20
David Yeh San Luis Obispo, CA Neurological Surgery $162,730.89
Grigory Goldberg Ocean, NJ Orthopaedic Surgery of The Spine $136,737.61
Jason Garber Las Vegas, NV Neurological Surgery $134,372.02
Donald Kucharzyk Crown Point, IN Pediatric Orthopaedic Surgery $131,976.68

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.